Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.
Journal: Transplantation
Published: June 23, 2025
Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study.
Journal: Transplantation
Published: June 23, 2025
Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma.
Journal: Cancer immunology research
Published: January 14, 2025
Region of Interest Detection in Melanocytic Skin Tumor Whole Slide Images - Nevus & Melanoma.
Journal: ArXiv
Published: May 27, 2024
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.
Journal: Blood
Published: February 27, 2023
NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 15, 2023
The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.
Journal: Therapeutic advances in hematology
Published: November 16, 2022
Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.
Journal: Cancer treatment and research
Published: May 13, 2022
Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis.
Journal: Bone marrow transplantation
Published: October 20, 2021
STEPS to Enhance Physical Activity After Hematopoietic Cell Transplantation for Multiple Myeloma.
Journal: Cancer nursing
Published: September 24, 2021
Meloxicam with Filgrastim may Reduce Oxidative Stress in Hematopoietic Progenitor Cells during Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Multiple Myeloma.
Journal: Stem cell reviews and reports
Published: September 02, 2021
Last Updated: 09/26/2026